• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I-间碘苄胍闪烁扫描术作为帕金森病跌倒预测指标的潜在效用

Potential Utility of I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease.

作者信息

Murakami Nagahisa, Sako Wataru, Haji Shotaro, Furukawa Takahiro, Otomi Yoichi, Otsuka Hideki, Izumi Yuishin, Harada Masafumi, Kaji Ryuji

机构信息

Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.

Department of Radiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.

出版信息

Front Neurol. 2019 Apr 12;10:376. doi: 10.3389/fneur.2019.00376. eCollection 2019.

DOI:10.3389/fneur.2019.00376
PMID:31031701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6473994/
Abstract

Falls are associated with poor prognosis in patients with Parkinson's disease (PD). Although several factors related to falls were reported in patients with PD, objective predictors of falls are not identified. We aimed to determine whether I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy could be a useful biomarker to predict falls. Forty-five patients with PD were enrolled in this study. These subjects were followed up more than 5 years after MIBG scintigraphy and were divided into two groups: one with decreased uptake of MIBG and the other without decreased uptake of MIBG. The cut-off value for the delayed heart-to-mediastinum ratio was 1.8. Kaplan-Meier analysis and a log-rank test were performed to test the predictive power of MIBG cardiac scintigraphy for falls. Univariate analysis was selected because we did not have appropriate data for adjustment, such as motor and cognitive assessment. The group with decreased uptake of MIBG had a significantly higher incidence of falls than that without decreased uptake of MIBG ( = 0.022, log-rank test). Although the limitations of this study were lack of several key factors including motor and cognitive assessment, MIBG cardiac scintigraphy may be used to predict falls in patients with PD.

摘要

跌倒与帕金森病(PD)患者的不良预后相关。尽管已有报道指出PD患者存在一些与跌倒相关的因素,但尚未确定跌倒的客观预测指标。我们旨在确定间碘苄胍(MIBG)心肌显像是否可作为预测跌倒的有用生物标志物。本研究纳入了45例PD患者。这些受试者在MIBG显像后随访了5年以上,并分为两组:一组MIBG摄取减少,另一组MIBG摄取未减少。延迟心纵隔比的临界值为1.8。采用Kaplan-Meier分析和对数秩检验来检验MIBG心肌显像对跌倒的预测能力。由于我们没有合适的调整数据,如运动和认知评估数据,因此选择了单因素分析。MIBG摄取减少组的跌倒发生率显著高于MIBG摄取未减少组(对数秩检验,P = 0.022)。尽管本研究存在包括缺乏运动和认知评估等几个关键因素的局限性,但MIBG心肌显像可能可用于预测PD患者的跌倒。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/6473994/0a4507ea74ad/fneur-10-00376-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/6473994/0a4507ea74ad/fneur-10-00376-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c03/6473994/0a4507ea74ad/fneur-10-00376-g0001.jpg

相似文献

1
Potential Utility of I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease.I-间碘苄胍闪烁扫描术作为帕金森病跌倒预测指标的潜在效用
Front Neurol. 2019 Apr 12;10:376. doi: 10.3389/fneur.2019.00376. eCollection 2019.
2
Retrospective analysis of parkinsonian patients exhibiting normal (123)I-MIBG cardiac uptake.对表现出正常(123)I-MIBG心肌摄取的帕金森病患者进行回顾性分析。
J Neurol Sci. 2015 Dec 15;359(1-2):236-40. doi: 10.1016/j.jns.2015.10.059. Epub 2015 Nov 4.
3
Sensitivity and specificity of cardiac I-MIBG scintigraphy for diagnosis of early-phase Parkinson's disease.心脏 I-MIBG 闪烁显像术诊断早期帕金森病的敏感性和特异性。
J Neurol Sci. 2019 Dec 15;407:116409. doi: 10.1016/j.jns.2019.07.027. Epub 2019 Jul 24.
4
Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.心脏自主神经去神经支配与新发帕金森病患者的痴呆:一项 7 年随访研究。
J Neurol Sci. 2017 Oct 15;381:291-295. doi: 10.1016/j.jns.2017.09.010. Epub 2017 Sep 8.
5
[Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].[帕金森病中的心脏交感神经功能障碍——123I-间碘苄胍闪烁显像结果与通过瓦尔萨尔瓦动作评估的自主神经功能之间的关系]
Rinsho Shinkeigaku. 2003 Aug;43(8):465-9.
6
Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.采用 MIBG 闪烁显像进行的序列影像学分析显示,帕金森病患者的心脏交感神经进行性退化。
Eur J Neurol. 2011 Jul;18(7):1010-3. doi: 10.1111/j.1468-1331.2010.03211.x. Epub 2010 Sep 16.
7
Striatal dopamine activity and myocardial I-metaiodobenzylguanidine uptake in early Parkinson's disease.纹状体多巴胺活性与早期帕金森病患者心肌 I-间位碘苄胍摄取。
Parkinsonism Relat Disord. 2019 Jun;63:156-161. doi: 10.1016/j.parkreldis.2019.02.012. Epub 2019 Feb 14.
8
I-MIBG myocardial scintigraphy for differentiation of Parkinson's disease from multiple system atrophy or essential tremor in Chinese population.中国人群中I-MIBG心肌闪烁显像用于帕金森病与多系统萎缩或特发性震颤的鉴别诊断
J Neurol Sci. 2017 Feb 15;373:48-51. doi: 10.1016/j.jns.2016.12.006. Epub 2016 Dec 7.
9
(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.(123)帕金森病中的碘代间位苄胍心肌闪烁显像
J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):189-94. doi: 10.1136/jnnp.67.2.189.
10
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.间碘苄胍心肌闪烁显像在帕金森病诊断中的可靠性
J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):249-51. doi: 10.1136/jnnp.2004.037028.

引用本文的文献

1
Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson's Disease: A Comprehensive Review.帕金森病的心脏123I-间碘苄胍(MIBG)闪烁扫描术:一项综述
Brain Sci. 2023 Oct 18;13(10):1471. doi: 10.3390/brainsci13101471.

本文引用的文献

1
Falls in Parkinson's disease: A complex and evolving picture.帕金森病患者的跌倒:一个复杂且不断变化的问题。
Mov Disord. 2017 Nov;32(11):1524-1536. doi: 10.1002/mds.27195. Epub 2017 Oct 25.
2
Cardiac sympathetic denervation and dementia in de novo Parkinson's disease: A 7-year follow-up study.心脏自主神经去神经支配与新发帕金森病患者的痴呆:一项 7 年随访研究。
J Neurol Sci. 2017 Oct 15;381:291-295. doi: 10.1016/j.jns.2017.09.010. Epub 2017 Sep 8.
3
Falling Direction can Predict the Mechanism of Recurrent Falls in Advanced Parkinson's Disease.
跌倒方向可预测晚期帕金森病患者跌倒的机制。
Sci Rep. 2017 Jun 20;7(1):3921. doi: 10.1038/s41598-017-04302-7.
4
The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.将多巴胺转运体的[123I]-FP-CIT单光子发射计算机断层扫描(SPECT)研究与[123I]-间碘苄胍(MIBG)心肌闪烁显像相结合,在鉴别帕金森病与其他退行性帕金森综合征中的应用。
Nucl Med Commun. 2017 Jun;38(6):487-492. doi: 10.1097/MNM.0000000000000674.
5
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease.Aβ42水平降低预示早期帕金森病中左旋多巴抵抗性步态进展。
Neurology. 2017 Apr 18;88(16):1501-1511. doi: 10.1212/WNL.0000000000003840. Epub 2017 Mar 22.
6
Imaging-based differential diagnosis between multiple system atrophy and Parkinson's disease.基于影像学的多系统萎缩与帕金森病的鉴别诊断
J Neurol Sci. 2016 Sep 15;368:104-8. doi: 10.1016/j.jns.2016.06.061. Epub 2016 Jun 29.
7
Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension.在帕金森病合并神经源性直立性低血压患者试验中,屈昔多巴与跌倒减少
Clin Neuropharmacol. 2016 Sep-Oct;39(5):220-6. doi: 10.1097/WNF.0000000000000168.
8
Motor dual-tasking deficits predict falls in Parkinson's disease: A prospective study.运动双重任务缺陷可预测帕金森病患者的跌倒:一项前瞻性研究。
Parkinsonism Relat Disord. 2016 May;26:73-7. doi: 10.1016/j.parkreldis.2016.03.007. Epub 2016 Mar 14.
9
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial.利斯的明治疗帕金森病患者步态稳定性的研究(ReSPonD):一项随机、双盲、安慰剂对照、2 期临床试验。
Lancet Neurol. 2016 Mar;15(3):249-58. doi: 10.1016/S1474-4422(15)00389-0. Epub 2016 Jan 13.
10
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.